676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)

Saved in:
Bibliographic Details
Title: 676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)
Authors: Lodise, Thomas1 (AUTHOR), Colman, Sam2 (AUTHOR), Alexander, Elizabeth3 (AUTHOR), Stein, Daniel3 (AUTHOR), Fitts, David3 (AUTHOR), Goldberg, Lisa3 (AUTHOR), Schranz, Jennifer3 (AUTHOR)
Source: Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS308-S309. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 139394976
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lodise%2C+Thomas%22">Lodise, Thomas</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Colman%2C+Sam%22">Colman, Sam</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alexander%2C+Elizabeth%22">Alexander, Elizabeth</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stein%2C+Daniel%22">Stein, Daniel</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fitts%2C+David%22">Fitts, David</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goldberg%2C+Lisa%22">Goldberg, Lisa</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schranz%2C+Jennifer%22">Schranz, Jennifer</searchLink><relatesTo>3</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Open+Forum+Infectious+Diseases%22">Open Forum Infectious Diseases</searchLink>. 2019 Supplement, Vol. 6, pS308-S309. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=139394976
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/ofid/ofz360.744
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S308
    Titles:
      – TitleFull: 676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lodise, Thomas
      – PersonEntity:
          Name:
            NameFull: Colman, Sam
      – PersonEntity:
          Name:
            NameFull: Alexander, Elizabeth
      – PersonEntity:
          Name:
            NameFull: Stein, Daniel
      – PersonEntity:
          Name:
            NameFull: Fitts, David
      – PersonEntity:
          Name:
            NameFull: Goldberg, Lisa
      – PersonEntity:
          Name:
            NameFull: Schranz, Jennifer
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 10
              Text: 2019 Supplement
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-print
              Value: 23288957
          Numbering:
            – Type: volume
              Value: 6
          Titles:
            – TitleFull: Open Forum Infectious Diseases
              Type: main
ResultId 1